More Good News for GLP-1 Agonists and Cancer RiskMore Good News for GLP-1 Agonists and Cancer Risk
(MedPage Today) — Women with nonmalignant uterine disease and a history of GLP-1 agonist and progestin treatment had a significantly lower risk of endometrial cancer (EC) compared with progestins alone, a retrospective study showed. Based on… (MedPage Today) — Women with nonmalignant uterine disease and a history of GLP-1 agonist and progestin treatment had Read More
Does Abortion or Miscarriage Contribute to Breast Cancer Risk?Does Abortion or Miscarriage Contribute to Breast Cancer Risk?
(MedPage Today) — A history of induced abortion or miscarriage was not associated with an increased risk of breast cancer, according to a Finnish case-control study.
For women with a history of one or more induced abortions compared with women…
The Scan by 2 Minute Medicine®: Daily caffeine intake linked to lower dementia risk, AAP sues over federal vaccine schedule overhaul, Catherine O’Hara passes away after short illness, and GLP-1 receptor agonists reduce endometrial cancer riskThe Scan by 2 Minute Medicine®: Daily caffeine intake linked to lower dementia risk, AAP sues over federal vaccine schedule overhaul, Catherine O’Hara passes away after short illness, and GLP-1 receptor agonists reduce endometrial cancer risk
The Scan by 2 Minute Medicine® is a pop-culture medical newsletter and exclusive benefit for 2 Minute Medicine Plus subscribers. Moderate caffeine intake linked to significantly lower dementia risk Recent longitudinal data suggests that your morning coffee or tea might be doing more than just waking you up. A massive study involving over 400,000 participants Read More
Blockbuster weight loss drugs like Ozempic deliver big results but face big questionsBlockbuster weight loss drugs like Ozempic deliver big results but face big questions
Three major reviews commissioned by the World Health Organization find that GLP-1 drugs including tirzepatide (sold as Mounjaro and Zepbound), semaglutide (Ozempic and Wegovy), and liraglutide (Victoza and Saxenda) can lead to substantial weight loss in people with obesity. But while the results are impressive, researchers caution that most trials were funded by drugmakers, long Read More
DNA barcoding reveals the complexity of breast cancer liquid biopsiesDNA barcoding reveals the complexity of breast cancer liquid biopsies
Australian scientists have discovered that DNA barcoding can be used to track cancer cells in solid and liquid biopsies, empowering future research into more reliable breast cancer diagnosis and treatment strategies. The work is published in Molecular Systems Biology.
Does a past abortion or miscarriage affect a woman’s risk of developing breast cancer?Does a past abortion or miscarriage affect a woman’s risk of developing breast cancer?
A prior abortion or miscarriage was not linked with an increased risk of developing pre- or postmenopausal breast cancer in a study published in Acta Obstetricia et Gynecologica Scandinavica.
Ozempic Pill Launching; Glucose Monitor Makers Warned; Thyroidectomy in Older AdultsOzempic Pill Launching; Glucose Monitor Makers Warned; Thyroidectomy in Older Adults
(MedPage Today) — The FDA approved three doses — 1.5 mg, 4 mg, and 9 mg — of a new oral semaglutide formulation for diabetes (Ozempic tablets), Novo Nordisk announced. An ad for Novo Nordisk’s weight loss pill version of semaglutide (Wegovy… (MedPage Today) — The FDA approved three doses — 1.5 mg, 4 Read More
GLP-1 drugs may protect the heart beyond weight loss, trial results suggestGLP-1 drugs may protect the heart beyond weight loss, trial results suggest
With the use of GLP-1 medications on the rise, cardiologists are seeing benefits to heart health, and it might not all be related to weight loss alone. GLP-1 medications, including semaglutide, are a class of drugs that act on receptors throughout the body, influencing insulin sensitivity, appetite regulation, inflammation and metabolic health. These therapies traditionally Read More
Denosumab discontinuation in non-metastatic breast cancer treated with AI raises vertebral fracture riskDenosumab discontinuation in non-metastatic breast cancer treated with AI raises vertebral fracture risk
Aromatase inhibitors (AIs) are a cornerstone of adjuvant therapy for hormone receptor–positive breast cancer, significantly reducing recurrence and mortality. However, by suppressing estrogen production, AIs accelerate bone loss and increase fracture risk. To counter this, antiresorptive therapies such as denosumab or bisphosphonates are widely recommended.
FDA Approves Semaglutide Pill for ObesityFDA Approves Semaglutide Pill for Obesity
This Medical News article discusses the US Food and Drug Administration approval of oral semaglutide for the treatment of obesity in adults. This Medical News article discusses the US Food and Drug Administration approval of oral semaglutide for the treatment of obesity in adults.